Proxy Votes Now

Home › Funds › RBB FUND, INC. › Boston Partners Long/Short Research Fund

Boston Partners Long/Short Research Fund (BPIRX) proxy voting record 2025-2026

Fund family: RBB FUND, INC. · Filed by RBB FUND, INC. (CIK 831114) · SEC series S000030191

Share classes and tickers: BPIRX (C000092913), BPRRX (C000092912)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 3,184 with, 147 against, 3 abstentions (not counted as with management); 10 items carried no recommendation; 1 split votes are in neither count. Shareholder proposals: 69 FOR, 81 AGAINST, 5 abstained, by the filing’s own vote-source field.

Compared with RBB FUND, INC. as a whole

The same two figures as RBB FUND, INC.’s manager page (32,541 ballot items across 32 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsRBB FUND, INC.Items
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)94.6%3,00093.2%28,258
Backed environmental and social shareholder proposals at US companies3.0%6611.4%324

Where this fund voted differently from most RBB FUND, INC. funds

Each ballot item this fund voted is set against the votes of the other RBB FUND, INC. funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most RBB FUND, INC. funds on 25 items (7.9% of the 317 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost RBB FUND, INC. fundsMgmtResult
Berkshire Hathaway Inc.2026-05-02Non-binding resolution to approve the compensation of the Company's Named Executive Officers, as described in the 2026 Proxy Statement.AgainstFOR — 7 of 7 RBB FUND, INC. fundsAgainstPassed (calculated), 93.0% support
Bristol-Myers Squibb Company2026-05-05Shareholder Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent DirectorForAGAINST — 3 of 3 RBB FUND, INC. fundsAgainstNot approved, 27.6% support
CVS Health Corporation2026-05-14Shareholder Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent.ForAGAINST — 3 of 3 RBB FUND, INC. fundsAgainst—
FedEx Corporation2025-09-29Advisory vote to approve named executive officer compensation.AgainstFOR — 5 of 6 RBB FUND, INC. fundsAgainstApproved, 63.4% support
Maplebear Inc.2026-05-22To approve, on a non-binding, advisory basis, the compensation of our named executive officers.AgainstFOR — 5 of 6 RBB FUND, INC. fundsAgainstApproved, 78.8% support
Meta Platforms, Inc.2026-05-27Shareholder A shareholder proposal regarding data protection impact assessment on generative Al chatbots.AgainstFOR — 4 of 5 RBB FUND, INC. fundsForNot approved, 6.6% support
Meta Platforms, Inc.2026-05-27Shareholder A shareholder proposal regarding report on addressing antisemitism and hate in online platforms.AgainstFOR — 4 of 5 RBB FUND, INC. fundsForNot approved, 6.6% support
Booking Holdings Inc.2026-06-02Amendment of the Company's certificate of incorporation to provide for the exculpation of officers.ForAGAINST — 4 of 5 RBB FUND, INC. fundsForApproved, 87.4% support
Maplebear Inc.2026-05-22To elect the following Class III director nominees: Lily SarafanWithholdFOR — 4 of 5 RBB FUND, INC. fundsAgainstElected, 83.3% support
Maplebear Inc.2026-05-22To elect the following Class III director nominees: Meredith Kopit LevienWithholdFOR — 4 of 5 RBB FUND, INC. fundsAgainstElected, 92.3% support
HCA Healthcare, Inc.2026-04-23Shareholder Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences.AgainstFOR — 5 of 7 RBB FUND, INC. fundsForNot approved, 10.9% support
Broadcom Inc.2026-04-20Advisory vote to approve the named executive officer compensation.AgainstFOR — 5 of 8 RBB FUND, INC. fundsAgainstApproved, 66.4% support
Wells Fargo & Company2026-04-28Advisory resolution to approve executive compensation (Say on Pay).AgainstFOR — 4 of 6 RBB FUND, INC. fundsAgainstPassed (calculated), 65.9% support
Salesforce, Inc.2026-05-28Amendment and restatement of our 2013 Equity Incentive Plan to increase the number of shares reserved for issuance and extend the plan term.AgainstFOR — 3 of 4 RBB FUND, INC. fundsAgainstPassed (calculated), 75.8% support
Alphabet Inc.2026-06-05Advisory vote to approve compensation awarded to named executive officersAgainstFOR — 3 of 5 RBB FUND, INC. fundsAgainstApproved, 81.1% support
Oracle Corporation2025-11-18Advisory Vote to Approve the Compensation of our Named Executive OfficersAgainstFOR — 3 of 5 RBB FUND, INC. fundsAgainstPassed (calculated), 81.9% support
Amgen Inc.2026-05-19Shareholder Stockholder proposal to require an independent board chairman.ForAGAINST — 3 of 5 RBB FUND, INC. fundsAgainstNot approved, 17.7% support
Visa Inc.2026-01-27Shareholder Shareholder proposal on shareholder right to act by written consent.ForAGAINST — 2 of 3 RBB FUND, INC. fundsAgainstNot approved, 33.0% support
Visa Inc.2026-01-27Shareholder Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair.ForAGAINST — 2 of 3 RBB FUND, INC. fundsAgainstNot approved, 16.2% support
Visa Inc.2026-01-27To approve amendments to our Eighth Restated Certificate of Incorporation to limit officer liability as permitted by Delaware Law.ForAGAINST — 2 of 3 RBB FUND, INC. fundsForApproved, 91.0% support
Lam Research Corporation2025-11-04Approval of an amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware law.ForAGAINST — 2 of 3 RBB FUND, INC. fundsFor—
FedEx Corporation2025-09-29Shareholder Stockholder proposal regarding independent board chairman.ForAGAINST — 2 of 3 RBB FUND, INC. fundsAgainstNot approved, 42.5% support
Cummins Inc.2026-05-12Shareholder Shareholder proposal to adopt a policy for separation of the roles of Chairperson and Chief Executive Officer.ForAGAINST — 2 of 3 RBB FUND, INC. fundsAgainstFailed (calculated), 22.5% support
Quest Diagnostics Incorporated2026-05-20Shareholder Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting.ForAGAINST — 2 of 3 RBB FUND, INC. fundsAgainstNot approved, 25.6% support
Omnicom Group Inc.2026-05-05Advisory resolution to approve executive compensation.AgainstFOR — 2 of 3 RBB FUND, INC. fundsAgainstApproved, 56.6% support

Download all 25 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 77.7% of this fund’s 3,334 such votes could be given a sector; the other 745 (22.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary560417.3%
Finance529275.1%
Health Care366195.2%
Industrials36082.2%
Technology353298.2%
Utilities18484.3%
Real Estate8300.0%
Consumer Staples7568.0%
Telecommunications2500.0%
Basic Materials2400.0%
Energy1900.0%
Miscellaneous1100.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2,2130
Audit-related2560
Corporate Governance23367
Say-on-Pay2070
Capital Structure1701
Compensation1604
Environment or Climate3634
Other Social Issues3528
Extraordinary Transactions170
Shareholder Rights and Defenses167

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Frontdoor, Inc.May 13, 2026$13M100
AbbVie Inc.May 8, 2026$10M81
JPMorgan Chase & Co.May 19, 2026$8M174
Wells Fargo & CompanyApril 28, 2026$7M216
Micron Technology, Inc.January 15, 2026$6M121
Johnson & JohnsonApril 23, 2026$6M151
Amgen Inc.May 19, 2026$6M151
US Foods Holding Corp.May 14, 2026$6M110

Notable votes against management

MeetingCompanyProposalFundMgmt
May 8, 2026AbbVie Inc.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalForAgainst
May 19, 2026JPMorgan Chase & Co.Report on congruence of security, resiliency, and climate initiatives Shareholder proposalAgainstFor
May 19, 2026JPMorgan Chase & Co.Independent board chairman Shareholder proposalForAgainst
April 28, 2026Wells Fargo & CompanyShareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair. Shareholder proposalForAgainst
April 28, 2026Wells Fargo & CompanyShareholder Proposal - Govern by Majority Vote. Shareholder proposalForAgainst
January 15, 2026Micron Technology, Inc.SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposalForAgainst
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalForAgainst
May 19, 2026Amgen Inc.Stockholder proposal to require an independent board chairman. Shareholder proposalForAgainst
May 4, 2026Bank of America CorporationShareholder proposal requesting independent board chair Shareholder proposalForAgainst
May 4, 2026Bank of America CorporationShareholder proposal requesting report on board oversight of risks related to animal welfare Shareholder proposalAgainstFor
May 7, 2026Corpay, Inc.Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting. Shareholder proposalForAgainst
June 2, 2026Booking Holdings Inc.Non-binding stockholder vote on a proposal to avoid brand damage due to corporate political spending. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

3,353 ballot items at 252 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Boston Partners Long/Short Research Fund (BPIRX) voted at 252 shareholder meetings of 243 companies, on 3,353 ballot items in all. Where management made a recommendation, the fund followed it on 95.5% of the items and voted against it 147 times. Its most frequent area of disagreement was corporate governance (67 of its votes against management). It voted FOR 46.0% of the 150 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than RBB FUND, INC.'s funds as a whole (94.6% against 93.2%). It voted differently from most RBB FUND, INC. funds on 25 items. 1 of its meetings was contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of RBB FUND, INC.’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.